Cancer Moonshot℠ – Funding Opportunities
The funding opportunity announcements (FOAs) listed below highlight research initiatives that align with the efforts of the Cancer Moonshot. They may be supported with existing funds or with the 21st Century Cures funding.
Planning for implementation of longer-term scientific initiatives is also underway. We will continue to update this page as new funding opportunities become available so check back often or sign up to receive automatic email updates on Cancer Moonshot-related activities.
More information about the recently announced funding opportunities is available on the Cancer Moonshot Funding Resources page.
Please note that all publications and data resulting from Cancer Moonshot funded initiatives will be required to be immediately accessible. For more information, see the Cancer Moonshot Public Access and Data Sharing Policy.
| BRP Recommendation | Title | Announcement Number | Opening Date | Expiration Date |
|---|---|---|---|---|
| Cancer Immunotherapy Translational Science Network | Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) | PAR-17-245 | 5/5/2017 | 5/8/2020 |
| Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) | PAR-17-244 | 5/5/2017 | 5/8/2020 | |
| Metabolic Reprogramming to Improve Immunotherapy (R21) | PAR-16-229 | 9/16/2016 | 9/8/2019 | |
| Metabolic Reprogramming to Improve Immunotherapy (R01) | PAR-16-228 | 9/5/2016 | 9/8/2019 | |
| Prevention and Early Detection: Implementation Science | Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01) | PAR-16-202 | 9/11/2016 | 6/14/2019 |
| Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21) | PAR-16-201 | 9/11/2016 | 6/14/2019 | |
| Dissemination and Implementation Research in Health (R21) | PAR-16-236 | 5/16/2016 | 5/8/2019 | |
| Dissemination and Implementation Research in Health (R01) | PAR-16-238 | 5/10/2016 | 5/8/2019 | |
| Fusion Oncoproteins in Childhood Cancers | Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer (Admin Supp) | PA-17-138 | 3/1/2017 | 3/29/2018 |
| Gene Fusions in Pediatric Sarcomas (R21) | PA-16-252 | 9/16/2016 | 5/8/2019 | |
| Gene Fusions in Pediatric Sarcomas (R01) | PA-16-251 | 9/5/2016 | 5/8/2019 | |
| Generation of Human Tumor Atlases | Emerging Questions in Cancer Systems Biology (U01) | PAR-16-131 | 5/24/2016 | 11/24/2018 |
| BRP Recommendation | Title | Announcement Number | Opening Date | Expiration Date |
|---|---|---|---|---|
| Cancer Immunotherapy Translational Science Network | Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp) | PA-17-248 | 5/15/2017 | 6/16/2017 |
| Canine Immunotherapy Trials and Correlative Studies (U01) | RFA-CA-17-001 | 2/7/2017 | 3/8/2017 | |
| Coordinating Center for Canine Immunotherapy Trials and Correlative Studies (U24) | RFA-CA-17-002 | 2/7/2017 | 3/8/2017 | |
| Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor Microenvironment (U01) | RFA-CA-17-015 | 2/7/2017 | 3/8/2017 | |
| Resource Center for the Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies (U24) | RFA-CA-17-016 | 2/7/2017 | 3/8/2017 | |
| Cancer Immune Monitoring and Analysis Centers (CIMACs) (U24) | RFA-CA-17-005 | 2/17/2017 | 3/18/2017 | |
| Cancer Immunologic Data Common (CIDC) (U24) | RFA-CA-17-006 | 2/17/2017 | 3/18/2017 | |
| Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics (R43/44) | PHS2018-1/ Topic 372 | 7/18/2017 | 10/20/2017 | |
| Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U01) | RFA-CA-17-051 | 11/19/2017 | 12/20/2017 | |
| Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U54) | RFA-CA-17-050 | 11/19/2017 | 12/20/2017 | |
| Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR) (U24) | RFA-CA-17-048 | 12/16/2017 | 1/17/2018 | |
| Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24) | RFA-CA-17-047 | 12/16/2017 | 1/17/2018 | |
| Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01) | RFA-CA-17-046 | 12/16/2017 | 1/17/2018 | |
| Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01) | RFA-CA-17-045 | 12/16/2017 | 1/17/2018 | |
| Fusion Oncoproteins in Childhood Cancers | Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54) | RFA-CA-17-049 | 10/15/2017 | 11/16/2017 |
| Generation of Human Tumor Atlases | Imaging-Based Tools for Longitudinal and Multi-Dimensional Mapping of the Tumor and its Microenvironment(R43/R44) |
PHS2018-1/ Topic 376 | 7/18/2017 | 10/20/2017 |
| Human Tumor Atlas Network: Data Coordinating Center (U24) | RFA-CA-17-036 | 12/18/2017 | 1/19/2018 | |
| Pre-Cancer Atlas (PCA) Research Centers (U2C) | RFA-CA-17-035 | 12/18/2017 | 1/19/2018 | |
| Human Tumor Atlas Research Centers (U2C) | RFA-CA-17-034 | 12/18/2017 | 1/19/2018 | |
| National Cancer Data Ecosystem | PDX Development and Trial Centers (PDTCs) (U54) | RFA-CA-17-003 | 2/3/2017 | 3/4/2017 |
| PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24) | RFA-CA-17-004 | 2/3/2017 | 3/4/2017 | |
| New Enabling Technologies | Integration and Validation of Emerging Technologies to Accelerate Cancer Research (R33) | RFA-CA-17-023 | 4/10/2017 | 5/11/2017 |
| Computer Aided Decision Support for Radiation Oncology (R43/R44) | PHS2018-1/ Topic 380 | 7/18/2017 | 10/20/2017 | |
| Diagnostic Imaging for Cancer Immunotherapies (R43/R44) | PHS2018-1/ Topic 375 | 7/18/2017 | 10/20/2017 | |
| Tools and Technologies for Monitoring RNA Modifications (R43) | PHS2018-1/ Topic 373 | 7/18/2017 | 10/20/2017 | |
| Activities to Promote Technology Research Collaborations (APTRC) for Cancer Research (Admin Supp) | PA-17-143 | 3/12/2017 | 12/13/2017 | |
| Prevention and Early Detection: Implementation Science | Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01) | RFA-CA-17-041 | 12/9/2017 | 1/10/2018 |
| Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS): Coordinating Center (U24) | RFA-CA-17-039 | 12/18/2017 | 1/19/2018 | |
| Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3) | RFA-CA-17-038 | 12/18/2017 | 1/19/2018 | |
| Symptom Management Research | Bridging the Guideline Implementation Gap: Clinical Decision-Support to Improve Cancer Symptom Management (R43/R44) |
PHS2018-1/ Topic 377 | 7/18/2017 | 10/20/2017 |
| Software Enabling Data Integration from Wearable Sensors to Generate Novel Analytics for Cancer Patients (R43/R44 | PHS2018-1/ Topic 379 | 7/18/2017 | 10/20/2017 | |
| Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability (U01) | RFA-CA-17-052 | 12/17/2017 | 1/18/2018 | |
| Coordinating Center for Research Centers for Improving Management of Symptoms During and Following Cancer Treatment (U24) | RFA-CA-17-043 | 12/17/2017 | 1/18/2018 | |
| Research Centers for Improving Management of Symptoms During and Following Cancer Treatment (UM1) | RFA-CA-17-042 | 12/17/2017 | 1/18/2018 | |
| Therapeutic Target Identification to Overcome Resistance | Mechanisms of Cancer Drug Resistance and Sensitivity (U54) | RFA-CA-17-009 | 2/3/2017 | 3/4/2017 |
| Mechanisms of Cancer Drug Resistance and Sensitivity: Coordinating Center (U24) | RFA-CA-17-044 | 12/5/2017 | 1/6/2018 |